Indazole compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 30, 2011
Grant Date -
Jun 24, 2010
app pub date -
Sep 29, 2009
filing date -
Oct 9, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Provided are compounds represented by the following formula (A-1) and formula (1), or salts thereof. The compounds of formula (A-1) and formula (1) or salts thereof have β3 adrenergic receptor agonist activity, and thus are useful as therapeutic and prophylactic agent for diabetes mellitus, obesity, hyperlipidemia, depression, diseases caused by gallstones or hypermotility of the biliary tract, diseases caused by hyperactivity of the digestive tract, interstitial cystitis, overactive bladder or urinary incontinence, or as therapeutic and prophylactic agents for diseases concomitant with decreased tears.
First Claim
Other Claims data not available
